Market Overview:
The global lupus nephritis market is expected to grow at a CAGR of 5.8% from 2018 to 2030. The growth in the market can be attributed to factors such as increasing prevalence of lupus nephritis, rising awareness about lupus nephritis, and technological advancements in the field of diagnosis and treatment of lupus nephritis. However, the high cost associated with diagnosis and treatment is expected to restrain the growth of this market during the forecast period. Based on type, the global lupus nephritis market can be segmented into diagnosed cases and medications. The diagnosed cases segment is further sub-segmented into histopathology confirmed cases and serology confirmed cases. The histopathology confirmed cases sub-segment is anticipated to account for a larger share of this market during the forecast period owing to increasing adoption rates of histopathological tests for diagnosing lupus nephritis across regions. Based on application, this market can be divided into hospitals, clinics, ambulatory surgical centers (ASCs), and pharmaceutical companies segments.
Product Definition:
Lupus nephritis is a kidney disease caused by lupus, a chronic autoimmune disease. It can damage the kidneys and impair their ability to filter waste and toxins from the blood. This can lead to high blood pressure, swelling, and other complications. Lupus nephritis is a serious complication of lupus that can lead to kidney failure if not treated.
Diagnose:
Diagnose is a Nephrology ( Kidney Disease ) software solution that helps urologists to manage patients with urinary stones and kidney diseases. It also helps in the detection of other kidney diseases such as renal tubular acidosis, chronic nephritis, acute nephritis and interstitial cystitis. The factors that propel the growth of this market include increasing prevalence of lupus nephritis coupled with rising awareness about its early diagnosis among physicians.
Medications:
Lupus Nephritis is a chronic condition in which the nephrotic syndrome occurs. The main symptoms are urological, including urinary frequency, dysuria, and urgency. Medications used for lupus nephritis include immunosuppressants (glucocorticoids), anti-infective agents/antibiotics, analgesics/NSAIDs (aspirin-like products), and antimalarials.
Application Insights:
Based on application, the market is segmented into hospitals, clinics and ambulatory surgical centers, and pharmaceutical companies. Hospitals held the largest share of more than 60% in 2017. The hospital-based settings are preferred for lupus nephritis treatment as it provides a safe environment for patients with complex medical conditions to access advanced healthcare services.
The rising prevalence of lupus across all age groups coupled with an increasing number of patients visiting hospitals due to symptoms related to kidney failure is anticipated to drive the hospital segment over the forecast period. In addition, a rise in awareness about early diagnosis and appropriate treatment procedures is expected to boost growth during this period.
Regional Analysis:
North America dominated the global market in 2017. The region is expected to maintain its position during the forecast period due to increasing awareness about lupus and rising healthcare expenditure. In addition, presence of key players in this region will also help maintain dominance.
Asia Pacific is anticipated to witness lucrative growth over the forecast period owing to increase in number of patients suffering from lupus nephritis coupled with rise in disposable income and improved healthcare infrastructure especially for outpatient settings.
Infectious diseases are among top three causes of death globally accounting for around 13% deaths annually or 3 million deaths per year according high estimates published by WHO (World Health Organization).
Growth Factors:
- Increasing incidence of lupus nephritis
- Growing awareness about lupus nephritis
- Rising prevalence of comorbidities associated with lupus nephritis
- Technological advancements in the diagnosis and treatment of lupus nephritis
- increasing healthcare expenditure
Scope Of The Report
Report Attributes
Report Details
Report Title
Lupus Nephritis Market Research Report
By Type
Diagnose, Medications
By Application
Hospitals, Clinics, Ambulatory Surgical Centers, Pharmaceutical Companies
By Companies
Roche, Merck, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, myVMC
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
193
Number of Tables & Figures
136
Customization Available
Yes, the report can be customized as per your need.
Global Lupus Nephritis Market Report Segments:
The global Lupus Nephritis market is segmented on the basis of:
Types
Diagnose, Medications
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Clinics, Ambulatory Surgical Centers, Pharmaceutical Companies
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Roche
- Merck
- Bristol-Myers Squibb
- Eli Lilly
- GlaxoSmithKline
- myVMC
Highlights of The Lupus Nephritis Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Diagnose
- Medications
- By Application:
- Hospitals
- Clinics
- Ambulatory Surgical Centers
- Pharmaceutical Companies
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Lupus Nephritis Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Lupus nephritis is a condition in which the kidneys are damaged by lupus. Lupus can also damage other organs in the body, including the heart and lungs.
Some of the major players in the lupus nephritis market are Roche, Merck, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, myVMC.
The lupus nephritis market is expected to register a CAGR of 5.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Lupus Nephritis Market Overview 4.1 Introduction 4.1.1 Market Taxonomy 4.1.2 Market Definition 4.1.3 Macro-Economic Factors Impacting the Market Growth 4.2 Lupus Nephritis Market Dynamics 4.2.1 Market Drivers 4.2.2 Market Restraints 4.2.3 Market Opportunity 4.3 Lupus Nephritis Market - Supply Chain Analysis 4.3.1 List of Key Suppliers 4.3.2 List of Key Distributors 4.3.3 List of Key Consumers 4.4 Key Forces Shaping the Lupus Nephritis Market 4.4.1 Bargaining Power of Suppliers 4.4.2 Bargaining Power of Buyers 4.4.3 Threat of Substitution 4.4.4 Threat of New Entrants 4.4.5 Competitive Rivalry 4.5 Global Lupus Nephritis Market Size & Forecast, 2020-2028 4.5.1 Lupus Nephritis Market Size and Y-o-Y Growth 4.5.2 Lupus Nephritis Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Diagnose
5.2.2 Medications
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Clinics
6.2.3 Ambulatory Surgical Centers
6.2.4 Pharmaceutical Companies
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Lupus Nephritis Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Lupus Nephritis Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Diagnose
9.6.2 Medications
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Clinics
9.10.3 Ambulatory Surgical Centers
9.10.4 Pharmaceutical Companies
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Diagnose
10.6.2 Medications
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Clinics
10.10.3 Ambulatory Surgical Centers
10.10.4 Pharmaceutical Companies
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Diagnose
11.6.2 Medications
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Clinics
11.10.3 Ambulatory Surgical Centers
11.10.4 Pharmaceutical Companies
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Diagnose
12.6.2 Medications
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Clinics
12.10.3 Ambulatory Surgical Centers
12.10.4 Pharmaceutical Companies
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Diagnose
13.6.2 Medications
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Clinics
13.10.3 Ambulatory Surgical Centers
13.10.4 Pharmaceutical Companies
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Lupus Nephritis Market: Competitive Dashboard
14.2 Global Lupus Nephritis Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Roche
14.3.2 Merck
14.3.3 Bristol-Myers Squibb
14.3.4 Eli Lilly
14.3.5 GlaxoSmithKline
14.3.6 myVMC